Alaunos Therapeutics (TCRT) EPS (Basic) (2009 - 2026)
Alaunos Therapeutics' (TCRT) quarterly EPS (Basic) came in at -$0.53 in Q1 2026, up 22.41% YoY from -$0.43 in Q1 2025, and down 13.67% on a QoQ basis from -$0.47 in Q4 2025.
Alaunos Therapeutics (TCRT) EPS (Basic) (2009 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 18 years of EPS (Basic) data on file, last reported at -$0.53 in Q1 2026.
- Quarterly EPS (Basic) rose 22.41% year-over-year to -$0.53 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.57 (down 1344.92% YoY) and the FY2025 annual result came in at -$111.79, down 3619.99% from the prior year.
- EPS (Basic) fell to -$0.53 in Q1 2026, from -$0.47 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.47 in Q4 2025 to a low of -$41.79 in Q2 2025.
- A 5-year average of -$5.67 and a median of -$5.06 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 90.68% — and 2025, when it tumbled 5638.93%.
- Tracing TCRT's EPS (Basic) over 5 years: stood at -$6.51 in 2022, then grew by 22.27% to -$5.06 in 2023, then surged by 90.68% to -$0.47 in 2024, then increased by 1.27% to -$0.47 in 2025, then declined by 13.67% to -$0.53 in 2026.
- The last three EPS (Basic) figures came in at -$0.53 (Q1 2026), -$0.47 (Q4 2025), and -$0.55 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | -0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.53 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -0.55 |
| Jun 30, 2025 | -41.79 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -0.47 |
| Sep 30, 2024 | -0.72 |
| Jun 30, 2024 | -0.73 |
| Mar 31, 2024 | -1.09 |
| Dec 31, 2023 | -5.06 |
| Sep 30, 2023 | -5.41 |
| Jun 30, 2023 | -5.68 |
| Mar 31, 2023 | -6.62 |
| Dec 31, 2022 | -6.51 |
| Sep 30, 2022 | -6.32 |
| Jun 30, 2022 | -6.93 |
| Mar 31, 2022 | -6.83 |
| Dec 31, 2021 | -8.26 |
| Sep 30, 2021 | -15.90 |
| Jun 30, 2021 | -15.86 |